Zidovudine oral sol.10mg/ml/BOT-100ml

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Zidovudine oral solution 10mg/ml, bottle 100ml with oral dispensing syringe

Technical Specifications:
Each 1 ml oral solution contains Zidovudine 10mg. Pack comes with oral dispensing syringe

Therapeutic class:
Zidovudine (AZT) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI).

Standard shelf life:
36 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in adults and children in combination with at least two other antiretroviral drugs. By mouth (oral), PO
PMTCT: In combination with other drugs for prevention of mother-to child HIV transmission.

Packaging and storage:
Do not store above 30ºC (86ºF).
Store in tightly closed original container
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items